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Potential Synergy between SNP and CpG-A or IL-1b in
Regulating Transcriptional Activity of IL-20 Promoter
Lanqi Wang1, Kejia Li1, Qiannan Xu1, Xiaoying Chen1, Feng Xue1, Ruofei Shi1 and Jie Zheng1
Psoriasis is a multifactorial cutaneous disorder that in many aspects is influenced by both genetic and
environmental elements. IL-20, a member of IL-10 family, is found to be involved in the development of psoriasis.
In our previous study, a single-nucleotide polymorphism (SNP) of IL-20-1723C-G (rs1713239) was found to be
associated with psoriasis progression, especially in those induced by upper respiratory tract infection. To further
explore the underlying mechanism, we investigated the function of this specific variant and its cooperative effect
with bacterial-like DNA or IL-1b on regulating IL-20 expression. We found that in HaCat cells, both IL-1b and
CpG-A triggered a stronger IL-20 promoter activity with the risk-associated G allele in comparison with the nonrisk
C allele of rs1713239. Furthermore, on stimulation with IL-1b or CpG-A, an increased level of IL-20 expression was
also observed in psoriatic lesions of patients carrying the risk-associated G allele. This study demonstrates that
rs1713239 and infection may have potential synergetic effect on modulating the transcriptional activity of IL-20.
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INTRODUCTION
Psoriasis (Online Mendelian Inheritance in Man (OMIM)
#177900) is a chronic skin disorder characterized by infiltra-
tion of inflammatory elements, keratinocyte hyperprolifera-
tion, and altered differentiation. Although the etiology of
psoriasis remains obscure, several factors including genetic
susceptibility and environmental effects have been implicated
(Nestle et al., 2009).
IL-20 is a member of IL-10 family and its gene is located on
chromosome 1q32 (Blumberg et al., 2001). It is expressed
widely in different cell types (Dumoutier et al., 2001). In the
skin, it is mainly expressed by keratinocytes in the epidermis
and CD68(þ )/CD11c(þ ) myeloid-derived cells in the dermis
(Romer et al., 2003; Kunz et al., 2006; Wang et al., 2006). The
effect of IL-20 on keratinocyte proliferation and differentiation
was shown in an experimental reconstituted human epidermis
(Sa et al., 2007). IL-20 transgenetic mice skin shows a
thickened epidermis, hyperkeratosis, and compact stratum
corneum in hematoxylin and eosin staining section
(Blumberg et al., 2001). Moreover, a series of single-
nucleotide polymorphisms (SNPs) in the IL-20 gene have
been found to be associated with psoriasis (Kingo et al.,
2004; Koks et al., 2005; Chen et al., 2011).
Our previous study revealed that the SNP rs1713239
within the promoter region of IL-20 is related to patients
with a history of psoriasis triggered or exacerbated by an
upper respiratory tract infection in Chinese Han population
(Chen et al., 2011). However, little is known about the
function of this particular SNP and its interaction with
bacterial infection.
Bacterial infection has a significant impact on the develop-
ment of psoriasis (England et al., 1997; Brown et al., 2000;
Gudjonsson et al., 2003; El-Rachkidy et al., 2007). It has been
reported that bacterial DNA containing unmethylated
nucleotides with the particular sequence motif CG triggers
innate immune responses to produce proinflammatory
cytokines and chemokines via binding to Toll-like receptor 9
(Krieg, 2006). Bacterial DNA is also involved in the activation
of pathogenetic T cells and the production of IFN-a, which in
all link to the development of psoriasis (Cai et al., 2009).
In this study, we aim to continue the former study (Chen
et al., 2011) to analyze the function of the SNP (rs1713239).
We examine its interaction with bacterial-like DNA and
their effect on IL-20 expression to investigate the interaction
between genetic susceptibility and environmental factor in the
pathogenesis of psoriasis.
RESULTS
Induction of IL-20 by CpG-A
It has been reported that CpG-oligodeoxynucleotides (ODNs)
can activate human keratinocytes (Lebre et al., 2007). In order
to examine IL-20 expression in human keratinocytes upon
bacterial DNA stimulation, HaCat cells were treated with
CpG-A mimicking bacterial DNA. Real-time quantitative PCR
results showed that CpG-A upregulated IL-20 mRNA
expression in HaCat cells (one-way analysis of variance
(ANOVA) showed Po0.0001, least significant difference test
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showed P-value compared with the phosphate-buffered saline
(PBS) group, CpG-A: Po0.0001, Figure 1a). Moreover, IL-20
mRNA expression was maximized after 5 hours of 1mM CpG-A
stimulation (one-way ANOVA showed P¼ 0.003, least sig-
nificant difference test showed P¼ 0.017 at 5 hours,
Figure 1b). The results also showed that CpG-mediated IL-20
mRNA expression in HaCat cells was dose dependent
(Figure 1b). IL-20 expression in keratinocytes isolated from
skin lesions of psoriatic patients was also measured by flow
cytometry (36 psoriasis vulgaris patients). Data showed that
IL-20 expression was induced upon stimulation of CpG-A
(P¼ 0.002, nonparametric Wilcoxon signed-ranks test,
Figure 1c). We also measured IL-20 expression in the super-
natant by ELISA (13 psoriatic patients) and showed similar
result (P¼0.016, nonparametric Wilcoxon signed-ranks test,
Figure 1d). However, non-CpG DNA failed to upregulate
IL-20 expression in keratinocytes (P¼ 0.507, nonparametric
Wilcoxon signed-ranks test, Figure 1d). These results
suggest that IL-20 expression is upregulated by CpG-A in
keratinocytes.
SNP rs1713239 G allele and C allele regulate IL-20 promoter
activity differently
As SNP rs1713239 locates 1,723 bp upstream of IL-20 tran-
scription starting site, a series of functional analysis have been
conducted to evaluate its impact on IL-20 gene expression,
including in vitro reporter assays to evaluate the effect of
different SNP alleles within the promoter region on IL-20
promoter activity. The promoter sequences of IL-20 carrying
different SNP alleles were cloned into luciferase reporter
vectors (pGL4.15). The two reporter vectors were then
transiently transfected into the HaCat and HEK293t cells. Both
constructs showed positive promoter activity. The vector C
produced higher luciferase activity than the negative control of
pGL4.15-basic vector (HaCat cells: P¼ 0.006, HEK293t cells:
P¼0.001, two tailed by Student’s t-test, Figure 2), whereas
cloned promoter sequence with the risk-associated G allele
(vector G) gave a stronger luciferase activity than that
carrying C allele (HaCat cells: P¼ 0.001732, HEK293t cells:
P¼0.01966, two tailed by Student’s t-test, Figure 2).
Upregulation of G allele promoter activity with stimulation of
CpG-A or IL-1b
In order to investigate whether bacterial DNA and SNP
rs1713239 together have any effect on regulating the IL-20
promoter activity, HaCat cells transfected with the promoter
construct carrying G allele (vector G) or C allele (vector C)
were stimulated with CpG-A, IL-1b, or lipopolysaccharide
(LPS). Data showed that CpG-A or IL-1b further upregulated
the promoter activity in cells carrying the G allele (one-way
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Figure 1. Induction of IL-20 by CpG-A. (a) HaCat cells were treated with CpG-A (1mM  5 hours), IL-1b (10 ng ml1  1 hour), or lipopolysaccharide (LPS;
100mg ml 1 0.5, 1.5, 3, or 6 hours). (b) HaCat cells were treated with 1mM CpG-A for different time periods (0, 2.5, 5, 7, 9, and 12 hours) or CpG-A for 5 hours
at different dosages (1 and 10mM). Bars indicate mean±SD of experiment groups. (c) Keratinocytes isolated from psoriatic lesions were treated with 1mM CpG-A for
24 hours (n¼36). IL-20 expression was measured by FACS. hIL-20, human IL-20. (d) Keratinocytes isolated from psoriatic lesions were treated with 1mM CpG-A,
1mM non-CpG DNA, or 10 ng ml1 IL-1b for 24 hours (n¼ 13). Supernatant IL-20 expression was measured by ELISA. Data indicate median of tested individuals.
*Po0.05; **Po0.01 compared with phosphate-buffered saline (PBS)–treated group.
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ANOVA showed P¼0.004, least significant difference test
showed P-value compared with PBS group, CpG-A: P¼ 0.014;
IL-1b: P¼0.011), but not those with C allele (one-way
ANOVA showed P¼0.409, least significant difference test
showed P-value compared with PBS group, CpG-A: P¼ 0.732;
IL-1b: P¼ 0.762, Figure 3a). Nevertheless, the promoter
activity remained unaltered on LPS stimulation (one-way
ANOVA, C allele: P¼ 0.214; G allele: P¼0.255, Figure 3b).
NF-jB regulates IL-20 promoter activity through the SNP
rs1713239–independent pathway
NF-kB is an important transcriptional factor to be involved
in the regulation of the host innate antimicrobial response
(Carmody and Chen, 2007). In this study, HaCat cells were
co-transfected with promoter constructs and NF-kB P65
subunit eukaryotic expression vector. With expression of
P65, the luciferase activity of promoter constructs elevated.
As shown in Figure 4a, both G and C allele luciferase activities
increased after 100 ng P65 expression vector transfection
(vector C: P¼0.010, vector G: P¼0.015, two tailed by
Student’s t-test). The increase of luciferase activities was
similar between the C and G allele groups (P¼ 0.884, two
tailed by Student’s t-test, Figure 4b).
The expression of IL-20 is associated with the CpG-A or IL-1b
stimulation and SNP rs1713239
Samples were collected from a total of 36 psoriasis vulgaris
patients. Of all the patients individually genotyped for the
IL-20 SNP rs1713239, 23 patients were homozygous for C
allele (C group) and 13 were homozygous for the risk-
associated G allele (G group). They were then divided into
two groups according to the allele status. Among them, 28
skin samples were analyzed by real-time quantitative PCR.
Keratinocytes isolated from skin lesions in all patients were
treated with CpG-A, whereas those from 25 samples were
treated with IL-1b separately. Then, IL-20 expression was
analyzed by flow cytometry (Figure 5a). A higher IL-20 mRNA
expression level was observed in the G group when compared
with the C group, but the difference had no significance
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Figure 2. Luciferase assay of IL-20 promoter region. Difference of promoter
activity between the C and G alleles of rs1713239 in HaCat cells and HEK293t
cells. Bars indicate mean±SD of experiment groups. Representative results
were obtained from three independent experiments. *Po0.05 and **Po0.01.
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Figure 3. Alteration of the promoter activity between the G and C alleles of rs1713239 upon stimulation. (a) HaCat cells transfected with the promoter constructs
were treated with CpG-A(1mM) or IL-1b (10 ng ml1) for 24 hours and analyzed by luciferase assays. (b) HaCat cells transfected with the promoter constructs were
treated with lipopolysaccharide (LPS; 100mg ml1 0, 6, 12, and 24 hours) and analyzed by luciferase assays. Bars indicate mean±SD of experiment groups.
*Po0.05 compared with the phosphate-buffered saline (PBS)–treated group. Representative results were obtained from three independent experiments.
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Figure 4. Alteration of the promoter activity between the G and C alleles of
rs1713239 with the existence of NF-jB P65. (a) HaCat cells were transfected
with the promoter constructs and 100 ng NF-kB P65 expression constructs, and
analyzed by using luciferase assays after 24 hours. (b) Fold difference of
luciferase activity between C allele group and G allele group. Bars indicate
mean±SD of experiment groups. *Po0.05 compared with the phosphate-
buffered saline (PBS)–treated group. NS, not significant. Representative results
were obtained from three independent experiments.
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(P¼ 0.091, Mann–Whitney test, Figure 5b). However, IL-20
protein expression in keratinocytes of patients carrying G
allele is higher than that in keratinocytes with C allele
(P¼0.042, Mann–Whitney test, Figure 5c). Moreover, when
keratinocytes were treated with CpG-A or IL-1b, both stimu-
lants were able to upregulate the IL-20 expression in the G
allele group but not in the C allele group (CpG-A: C group,
P¼0.086; G group, P¼0.015; IL-1b: C group, P¼ 0.093; G
group, P¼ 0.011, nonparametric Wilcoxon signed-ranks test,
Figure 5d and e).
DISCUSSION
IL-20 is an important inflammatory cytokine involving in the
pathogenesis of psoriasis. Its mRNA and protein expression are
found to be elevated in psoriatic skin lesion as opposed to the
normal skin of the same individual. In addition, its mRNA
expression in psoriatic patients decreases in accordance with
clinical remission after calcipotriol treatment (Romer et al.,
2003). There are a variety of stimulants that can induce IL-20
expression in human keratinocytes, including IL-1a, IL-1b,
IL-6, IL-22, and hypoxia. Among them, IL-1b is the most
potent inducer, whereas LPS cannot promote IL-20 expression
in keratinocytes (Otkjaer et al., 2007; Chen and Chang, 2009;
Wolk et al., 2009). As keratinocytes constitutively express
Toll-like receptor 9 (Lebre et al., 2007), bacterial DNA
activates keratinocytes through binding to this receptor.
Nevertheless, little has been known about whether bacterial
DNA can induce IL-20 expression in keratinocytes. In this
study, we showed that CpG-A (mimic bacterial DNA) can
upregulate the IL-20 expression in human keratinocytes,
whereas non-CpG DNA cannot. It indicates that IL-20 is a
bacterial-like DNA-responsive gene and CpG-A can
upregulate IL-20 expression in human keratinocytes.
Our previous study has identified a link between SNP
rs1713239 and psoriasis (Chen et al., 2011). The frequency
of G allele is higher in psoriatic patients than in healthy
individuals. Interestingly, within the psoriatic pool, the G
allele frequency in patients with a history of bacterial infection
is also higher. Although it is clear that T cells play a major
determinant role in local inflammation that lead to the
characteristic manifestations of psoriasis ((Cai et al., 2011;
Di Cesare et al., 2009), recent studies of skin immune defense
systems have highlighted the importance of innate immunity
(Lande et al., 2007; Shklovskaya et al., 2011). When foreign
antigens like bacterial DNA activate innate immune response,
preinflammatory cytokines including IL-1b are released
(Abdul-Sater et al., 2009). In inflamed skin, keratinocytes are
the main source of IL-1b, and IL-1b can promote further
T cell–dependent cutaneous inflammation (Cai et al., 2011;
Renne et al., 2010). Elevated IL-20 mRNA expression occurs
within 0.5 hours after IL-1b treatment and elevated IL-20
protein expression occurs 3 hours later (Otkjaer et al., 2007).
It suggestes that IL-1b acts as an important modulator in the
induction of IL-20 expression. All these findings raise a
possibility that SNP rs1713239 may cooperate with either
bacterial-like DNA or IL-1b to regulate IL-20 expression.
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Figure 5. IL-20 expression in the skin lesions of patients with different alleles for rs1713239. (a) Keratinocytes from skin lesions of psoriatic patients were
stimulated with CpG-A (1mM), IL-1b (10 ng ml1), or phosphate-buffered saline (PBS; control) for 24 hours. IL-20 expression was analyzed by FACS.
(b) IL-20 mRNA expression in psoriatic lesions with different alleles for rs1713239: 17 patients in C allele group and 11 patients in G allele group. (c–e) Percentage
of IL-20-producing keratinocytes in psoriatic lesions, (c) without stimulation (C allele group n¼23; G allele group n¼ 13), (d) on CpG-A stimulation (C allele
group n¼ 23; G allele group n¼13), and (e) on IL-1b stimulation (C allele group n¼ 17; G allele group n¼ 8). Data represent median of tested individuals.
*Po0.05. NS, not significant.
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In our study, it has been observed that the risk-associated
G allele possesses higher promoter activity as compared with
the C allele, and the promoter activity can be further increased
upon stimulation with either CpG-A or IL-1b. These results
demonstrate that the SNP affects the promoter activity and
bacterial-like DNA or IL-1b can enhance the effect. At the
same time, we collected skin samples of psoriasis vulgaris
patients. In psoriatic patient samples, there is a higher trend of
IL-20 mRNA in the G group as compared with the C group,
but the difference has no significance. It may be because of
the small sample size, which needs additional samples to
validate. But the number of IL-20-producing keratinocytes in
the G group is higher than that in the C group, and the IL-20
expression is further upregulated by CpG-A or IL-1b.
However, it only harbors a higher trend of IL-20 expression
in keratinocytes of the C group on the same stimulation. The
increase in G group is significantly more than that in C group.
This observation indicates that patients who carry the risk-
associated G allele have more IL-20 expression upon
stimulation of CpG-A or IL-1b. The SNP and CpG-A or IL-1b
have potential synergy in regulating IL-20 expression.
IL-1b stimulates IL-20 expression through p38 mitogen-
activated protein kinase and NF-kB-dependent pathway
(Otkjaer et al., 2007). Treatment of keratinocytes with
CpG-ODNs leads to the translocation of NF-kB P65 (Lebre
et al., 2007). NF-kB is a family of ubiquitous transcription
factors with diverse physiological functions. NF-kB trans-
cription factor family has five members; among them, P65
participates in the positive transcriptional regulation and plays
an important role in innate and adaptive immunity (Okubo
et al., 2002). In our study, P65 increased IL-20 promoter
activity. It is consistent with that published—IL-20 promoter
region possesses NF-kB-binding sites (Otkjaer et al., 2007).
However, the increased level of promoter activity is similar in
the G and C allele groups, which implies that the SNP
function acts through NF-kB-independent pathway.
There are several limitations that need to be considered
when interpreting the results of this study. First, there are
not sufficient heterozygous individuals to conduct research
on interaction between C and G alleles. Second, although our
molecular studies do support rs1713239 to be functional,
the functional analysis can be improved further. With more
samples collected in future, we may include more functional
analysis to further validate the results in this study.
In conclusion, our results suggest that SNP rs1713239 and
bacterial-like DNA or IL-1b have potential synergic interaction
in regulating IL-20 promoter activity. This could also be
in connection with the higher G allele frequency of
SNP rs1713239 observed in psoriatic patients with upper
respiratory tract infection.
MATERIALS AND METHODS
Patients
This study has been approved by the Research Ethics Committee of
Shanghai Jiaotong University, School of Medicine, and conducted
according to the Declaration of Helsinki Principles. We obtained
written informed consent from all the participants. Patients
with psoriasis vulgaris were diagnosed based on clinical and
histopathological criteria (Schon and Boehncke, 2005). Except for
topical emollients, enrolled patients had not been treated with
systemic therapy at least 4 weeks before the study entry. A total of
36 participants aged 23–82 years (mean age 45±12.62 years) were
enrolled in this study. Biopsy samples of the skin lesions were then
collected from the waist of all psoriasis vulgaris patients.
CpG-ODNs
CpG-ODNs were synthesized by Sigma-Genosys (St Louis, MO).
Lowercase letters represent 5’ of phosphothiorate linkages and
uppercase letters represent 50 of phosphodiester linkages. The seq-
uences of the ODNs are: CpG-A, 50-ggTGCATCGATGCAGggggg-30,
non-CpG contains GpC dinucleotides instead of CpGs. The sequence
is 50-ggGGGAGCATGCTGgggggc-30. Bases in capital letters are
phosphodiester and those in lower case are phosphorothioate.
Primary human keratinocyte preparation and stimulation
The skin biopsy size was 1 1 cm by surgery and 19.63 mm2 by
punch (punch diameter is 5 mm). The depth of skin biopsy had
reached the subcutaneous fat layer. One part of the patients’ skin
biopsy sample was stored in TRIzol (Invitrogen, Life Technologies,
Carlsbad, CA) for real-time quantitative PCR and the other part was
incubated in dispase (GIBCO/Invitrogen, Life Technologies, Carlsbad,
CA) for 2 hours at 37 1C or at 4 1C overnight to separate epidermis
from dermis. Epidermal cell suspensions were prepared by incubating
epidermis in trypsin-EDTA (GIBCO/Invitrogen) for 10 minutes at
37 1C. Trypan blue staining showed that the survival rate of the cells
was 490%. Primary keratinocytes were cultured in Keratinocyte-SFM
(Gibco/Invitrogen). Patients’ keratinocytes were stimulated for
24 hours with 10 ng ml 1 IL-1b (eBioscience, San Diego, CA) or
1mM CpG-A in the presence of GolgiPlug (BD Biosciences, San Jose,
CA) for intracellular IL-20 staining.
Cell culture and stimulation
Human keratinocyte HaCat cells were purchased from ATCC
(Manassas, VA). Human embryo kidney epithelial cells, HEK293t
cells, were a gift from The Key Laboratory of Endocrine Tumors and
The Division of Endocrine and Metabolic Diseases, E-Institute of
Shanghai Universities, Shanghai, China. Both cell lines were cultured
in DMEM (GIBCO/Invitrogen) containing 10% fetal bovine serum
(GIBCO/Invitrogen). HaCat cells were then treated with 10 ng ml 1
IL-1b (eBioscience) for 1 hours, 100mg ml 1 LPS (Sigma-Aldrich, St
Louis, MO) for 6 hours, and 1mM CpG-A for 12 hours, and they were
then collected and analyzed with real-time quantitative PCR.
After transfection of reporter plasmids, HaCat cells were cultured in
DMEM containing 10% fetal bovine serum and treated with IL-1b,
CpG-A, or LPS for 24 hours. After treatment, the cells were collected
for luciferase assay analysis.
Luciferase assay analysis
Genomic DNA was isolated from the patients’ peripheral blood with
QIAGEN DNeasy kit (Qiagen, Germantown, MD) and B2.2 kb
( 2,000 to þ 200 bp from the first exon) of IL-20 was amplified by
PCR (sense primer 50-GGGGTACCATCACTTGCTCTGTGCTAAGT-30
and antisense primer 50-GAAGATCTTAGAGGCTTTCATCTTAGG
C-30). The fragment was cloned into the Kpn-I/Bgl-II site of the
pGL4.15-Basic vector (Promega, Madison, WI) to construct two
reporter plasmids carrying either  1723C (pGL4.15-C/vector C)
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or  1723G allele (pGL4.15-G/vector G) of rs1713239. The allelic
status of the reporter plasmid was verified by sequencing. For
transient transfection, cells were seeded in a sterile 24-well culture
plate at 105 cells per well and incubated for 24 hours. Each well was
transfected for 6 hours with 500 ng of pGL4.15-C or pGL4.15-G
encoding a modified firefly luciferase gene (or the empty pGL4.15
basic vector), co-transfected with 12.5 ng of pRL-SV40 (Promega)
encoding the Renilla luciferase gene. After 12 hours, the medium was
change to fresh DMEM with 10% fetal bovine serum in the presence
or absence of 10 ng ml 1 IL-1b, 1mM CpG-A, or 100mg ml 1 LPS.
After an additional 24 hours, cells were collected and analyzed for
luciferase activity. In addition, 500 ng of reporter plasmid (pGL4.15-C
or pGL4.15-G) and 50/100/200 ng NF-kB P65 expression plasmid (a
gift from The Key Laboratory of Endocrine Tumors and The Division
of Endocrine and Metabolic Diseases, E-Institute of Shanghai Uni-
versities) were co-transfected into human keratinocyte HaCat cells.
After 24 hours of culturing, cells were harvested and analyzed for
luciferase activity using Dual-Luciferase Reporter Assay System
(Promega). pRL-SV40 plasmid (Promega) was used as an internal
control. Lipofectamine 2000 (Invitrogen, Life Technologies, Carlsbad,
CA) was used in HEK293t cells and TranSmarter (Abmart, Shanghai,
China) was used in HaCat cells. All luciferase assays were carried out
in triplicate. Representative results were obtained from three inde-
pendent experiments.
Real-time quantitative PCR
Total RNAs from LPS-, CpG-A-, and IL1b-treated HaCat cells were
extracted using TRIzol (Invitrogen) and complementary DNA was
obtained using Reverse Transcription System (Promega) according to
the manufacturer’s protocol. Real-time PCR was performed using a
SYBR Green Premix Ex Taq (Takara, Dalian, China) in an Applied
Biosystems 7300 Machine. For real-time PCR analysis, the primer
sequences used for IL-20 mRNA were listed as follows (Romer et al.,
2003):
Forward primer 50-GCCAATTCCTTTClTACCATCAA-30 and
Reverse primer 50-CCCACAATGGCATGTCATGT-30.
Human glyceraldehyde-3-phosphate dehydrogenase was used as
internal reference.
All real-time quantitative PCRs were carried out in triplicates.
Representative results were obtained from three independent
experiments.
ELISA
Keratinocytes isolated from skin lesions of psoriatic patients were
seeded in a sterile 48-well culture plate at 105 cells per well and
incubated for 24 hours in the presence of 10 ng ml 1 IL-1b, 1mM
CpG-A, or 1mM non-CpG DNA. Supernatants were used to determine
the expression of IL-20 with a commercially available IL-20 ELISA kit
(R&D Systems, Minneapolis, MN) according to the manufacturer’s
instructions.
Flow cytometry analysis and intracellular staining
Keratinocytes isolated from skin lesions of psoriatic patients were
fixed, permeabilized using the Fix and Perm kit from BD Biosciences,
and stained intracellularly for IL-20 with mouse anti-hIL20 antibody
(code MAB1102, R&D Systems) or isotype antibody (code MAB002,
R&D Systems) for 30 minutes at 4 1C. Cells were then washed twice
with PBS and stained with donkey anti-mouse IgG antibody (code
A21202, Invitrogen) for 30 minutes at 4 1C. Patients’ lesion samples
were harvested with BD FACS Calibur (BD Biosciences) and analyzed
with FlowJo 7.6 (TreeStar, San Carlos, CA).
Statistical analysis
Normal distribution data were presented as mean±SD, whereas
median presents those that do not follow normality. Statistical analysis
was performed using paired t-test, Student’s t-test, or one-way
ANOVA for normal distribution data. Nonparametric Wilcoxon
rank-sum test or Mann–Whitney test was used to calculate the
significance between patients and healthy individuals. The P-value
of o0.05 was considered significant. Statistical analysis was con-
ducted using SPSS software 10.1 (SPSS, Chicago, IL).
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
This work is supported by the National Natural Science Foundation of China
(30872278 and 81171500), the Science and Technology Commission Founda-
tion of Shanghai, 2011 (11JC1407500), and the Doctorate Innovation Fund of
Medical School of Shanghai Jiaotong University (BXJ201207). We are most
grateful to all the patients who have willingly participated in this study.
REFERENCES
Abdul-Sater AA, Said-Sadier N, Ojcius DM et al. (2009) Inflammasomes bridge
signaling between pathogen identification and the immune response.
Drugs Today (Barc) 45(Suppl B):105–12
Blumberg H, Conklin D, Xu WF et al. (2001) Interleukin 20: discovery,
receptor identification, and role in epidermal function. Cell 104:9–19
Brown DW, Baker BS, Ovigne JM et al. (2000) Skin CD4þ T cells produce
interferon-gamma in vitro in response to streptococcal antigens in chronic
plaque psoriasis. J Invest Dermatol 114:576–80
Cai YH, Lu ZY, Shi RF et al. (2009) Enhanced proliferation and activation of
peripheral blood mononuclear cells in patients with psoriasis vulgaris
mediated by streptococcal antigen with bacterial DNA. J Invest Dermatol
129:2653–60
Cai YH, Shen XY, Ding CL et al. (2011) Pivotal Role of Dermal IL-17-Producing
gdT Cells in Skin Inflammation. Immunity 35:596–610
Carmody RJ, Chen YH (2007) Nuclear factor-kappaB: activation and regulation
during toll-like receptor signaling. Cell Mol Immunol 4:31–41
Chen WY, Chang MS (2009) IL-20 is regulated by hypoxia-inducible factor and
up-regulated after experimental ischemic stroke. J Immunol 182:5003–12
Chen XY, Jin LW, Chen YW et al. (2011) The association between the IL-20-
1723C–4G allele on the 1q chromosome and psoriasis triggered or
exacerbated by an upper respiratory tract infection in the Chinese Han
population. Dermatology 222:24–30
Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the
immunopathogenesis of psoriasis. J Invest Dermatol 129:1339–50
Dumoutier L, Leemans C, Lejeune D et al. (2001) Cutting edge: STAT
activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes
of two types. J Immunol 167:3545–9
El-Rachkidy RG, Hales JM, Freestone PP et al. (2007) Increased blood levels of
IgG reactive with secreted Streptococcus pyogenes proteins in chronic
plaque psoriasis. J Invest Dermatol 127:1337–42
England RJ, Strachan DR, Knight LC (1997) Streptococcal tonsillitis and
its association with psoriasis: a review. Clin Otolaryngol Allied Sci
22:532–5
Gudjonsson JE, Thorarinsson AM, Sigurgeirsson B et al. (2003) Streptococcal
throat infections and exacerbation of chronic plaque psoriasis: a
prospective study. Br J Dermatol 149:530–4
Kingo K, Koks S, Nikopensius T et al. (2004) Polymorphisms in the
interleukin-20 gene: relationships to plaque-type psoriasis. Genes Immun
5:117–21
L Wang et al.
Functional Study of a SNP in Psoriasis
394 Journal of Investigative Dermatology (2014), Volume 134
Koks S, Kingo K, Vabrit K et al. (2005) Possible relations between the
polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type
psoriasis. Genes Immun 6:407–15
Krieg AM (2006) Therapeutic potential of Toll-like receptor 9 activation. Nat
Rev Drug Discov 5:471–84
Kunz S, Wolk K, Witte E et al. (2006) Interleukin (IL)-19, IL-20 and IL-24 are
produced by and act on keratinocytes and are distinct from classical ILs.
Exp Dermatol 15:991–1004
Lande R, Gregorio J, Facchinetti V et al. (2007) Plasmacytoid dendritic cells
sense self-DNA coupled with antimicrobial peptide. Nature 449:564–9
Lebre MC, van der Aar AM, van Baarsen L et al. (2007) Human keratinocytes
express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol
127:331–41
Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496–509
Okubo Y, Oki N, Takeda H et al. (2002) Increased microorganisms DNA levels
in peripheral blood monocytes from psoriatic patients using PCR with
universal ribosomal RNA primers. J Dermatol 29:547–55
Otkjaer K, Kragballe K, Johansen C et al. (2007) IL-20 gene expression is
induced by IL-1beta through mitogen-activated protein kinase and NF-
kappaB-dependent mechanisms. J Invest Dermatol 127:1326–36
Renne J, Schafer V, Werfel T et al. (2010) Interleukin-1 from epithelial cells
fosters T cell-dependent skin inflammation. Br J Dermatol 162:1198–205
Romer J, Hasselager E, Norby PL et al. (2003) Epidermal overexpression of
interleukin-19 and -20 mRNA in psoriatic skin disappears after short-term
treatment with cyclosporine a or calcipotriol. J Invest Dermatol
121:1306–11
Sa SM, Valdez PA, Wu J et al. (2007) The effects of IL-20 subfamily cytokines
on reconstituted human epidermis suggest potential roles in cutaneous
innate defense and pathogenic adaptive immunity in psoriasis. J Immunol
178:2229–40
Schon MP, Boehncke WH (2005) Psoriasis. N Engl J Med 352:1899–912
Shklovskaya E, O’Sullivan Brendan J, Ng Lai Guan et al. (2011) Langerhans
cells are precommitted to immune tolerance induction. Proc Natl Acad
Sci USA 108:18049–54
Wang F, Lee E, Lowes M A et al. (2006) Prominent production of IL-20 by
CD68(þ )/CD11c(þ )myeloid-derived cells in psoriasis: gene regulation
and cellular effects. J Invest Dermatol 126:1590–9
Wolk K, Witte E, Warszawska K et al. (2009) The Th17 cytokine IL-22 induces
IL-20 production in keratinocytes: a novel immunological cascade with
potential relevance in psoriasis. Eur J Immunol 39:3570–81
L Wang et al.
Functional Study of a SNP in Psoriasis
www.jidonline.org 395
